243 related articles for article (PubMed ID: 16829519)
21. Coactivators p300 and PCAF physically and functionally interact with the foamy viral trans-activator.
Bannert H; Muranyi W; Ogryzko VV; Nakatani Y; Flügel RM
BMC Mol Biol; 2004 Sep; 5():16. PubMed ID: 15350211
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation.
Jin YH; Jeon EJ; Li QL; Lee YH; Choi JK; Kim WJ; Lee KY; Bae SC
J Biol Chem; 2004 Jul; 279(28):29409-17. PubMed ID: 15138260
[TBL] [Abstract][Full Text] [Related]
23. Regulation of histone acetyltransferase activity of p300 and PCAF by proto-oncogene protein DEK.
Ko SI; Lee IS; Kim JY; Kim SM; Kim DW; Lee KS; Woo KM; Baek JH; Choo JK; Seo SB
FEBS Lett; 2006 May; 580(13):3217-22. PubMed ID: 16696975
[TBL] [Abstract][Full Text] [Related]
24. p73gamma transactivates the p21 promoter through preferential interaction with the p300/CBP-associated factor in human prostate cancer cells.
Momii Y; Izumi H; Shiota M; Onitsuka T; Abe T; Kobayashi H; Miyamoto N; Uchiumi T; Kohno K
Oncol Rep; 2007 Aug; 18(2):411-6. PubMed ID: 17611664
[TBL] [Abstract][Full Text] [Related]
25. Histone Acetyltransferase (HAT) P300/CBP Inhibitors Induce Synthetic Lethality in PTEN-Deficient Colorectal Cancer Cells through Destabilizing AKT.
Liu Y; Yang EJ; Shi C; Mou PK; Zhang B; Wu C; Lyu J; Shim JS
Int J Biol Sci; 2020; 16(11):1774-1784. PubMed ID: 32398948
[TBL] [Abstract][Full Text] [Related]
26. GCN5: a supervisor in all-inclusive control of vertebrate cell cycle progression through transcription regulation of various cell cycle-related genes.
Kikuchi H; Takami Y; Nakayama T
Gene; 2005 Feb; 347(1):83-97. PubMed ID: 15715965
[TBL] [Abstract][Full Text] [Related]
27. Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation.
Nagy Z; Tora L
Oncogene; 2007 Aug; 26(37):5341-57. PubMed ID: 17694077
[TBL] [Abstract][Full Text] [Related]
28. MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation.
Jin Y; Zeng SX; Dai MS; Yang XJ; Lu H
J Biol Chem; 2002 Aug; 277(34):30838-43. PubMed ID: 12068014
[TBL] [Abstract][Full Text] [Related]
29. Site-specific acetylation of the fetal globin activator NF-E4 prevents its ubiquitination and regulates its interaction with the histone deacetylase, HDAC1.
Zhao Q; Cumming H; Cerruti L; Cunningham JM; Jane SM
J Biol Chem; 2004 Oct; 279(40):41477-86. PubMed ID: 15273251
[TBL] [Abstract][Full Text] [Related]
30. Regulation of ERK1 gene expression by coactivator proteins.
Chu BY; Tran K; Ku TK; Crowe DL
Biochem J; 2005 Dec; 392(Pt 3):589-99. PubMed ID: 16050810
[TBL] [Abstract][Full Text] [Related]
31. Probing lysine acetylation in proteins: strategies, limitations, and pitfalls of in vitro acetyltransferase assays.
Dormeyer W; Ott M; Schnölzer M
Mol Cell Proteomics; 2005 Sep; 4(9):1226-39. PubMed ID: 15933374
[TBL] [Abstract][Full Text] [Related]
32. Glucocorticoid-stimulated preadipocyte differentiation is mediated through acetylation of C/EBPbeta by GCN5.
Wiper-Bergeron N; Salem HA; Tomlinson JJ; Wu D; Haché RJ
Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2703-8. PubMed ID: 17301242
[TBL] [Abstract][Full Text] [Related]
33. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells.
Li DM; Sun H
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15406-11. PubMed ID: 9860981
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter.
Wang L; Grossman SR; Kieff E
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):430-5. PubMed ID: 10618435
[TBL] [Abstract][Full Text] [Related]
35. The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60.
Patel JH; Du Y; Ard PG; Phillips C; Carella B; Chen CJ; Rakowski C; Chatterjee C; Lieberman PM; Lane WS; Blobel GA; McMahon SB
Mol Cell Biol; 2004 Dec; 24(24):10826-34. PubMed ID: 15572685
[TBL] [Abstract][Full Text] [Related]
36. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.
Imbriano C; Gurtner A; Cocchiarella F; Di Agostino S; Basile V; Gostissa M; Dobbelstein M; Del Sal G; Piaggio G; Mantovani R
Mol Cell Biol; 2005 May; 25(9):3737-51. PubMed ID: 15831478
[TBL] [Abstract][Full Text] [Related]
37. In vitro transcription system delineates the distinct roles of the coactivators pCAF and p300 during MyoD/E47-dependent transactivation.
Dilworth FJ; Seaver KJ; Fishburn AL; Htet SL; Tapscott SJ
Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11593-8. PubMed ID: 15289617
[TBL] [Abstract][Full Text] [Related]
38. Acetylation of the foamy virus transactivator Tas by PCAF augments promoter-binding affinity and virus transcription.
Bodem J; Kräusslich HG; Rethwilm A
J Gen Virol; 2007 Jan; 88(Pt 1):259-263. PubMed ID: 17170459
[TBL] [Abstract][Full Text] [Related]
39. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation.
Ito A; Kawaguchi Y; Lai CH; Kovacs JJ; Higashimoto Y; Appella E; Yao TP
EMBO J; 2002 Nov; 21(22):6236-45. PubMed ID: 12426395
[TBL] [Abstract][Full Text] [Related]
40. Regulation of E2F1 activity by acetylation.
Martínez-Balbás MA; Bauer UM; Nielsen SJ; Brehm A; Kouzarides T
EMBO J; 2000 Feb; 19(4):662-71. PubMed ID: 10675335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
